Primary Care Clinics in Fairfield, IL Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Southern Illinois Primary Care Associates, P.c. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470 Fax: 618-842-3437 |
Medical Services Unlimited Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 1411 W Main St, Westport Plaza, Fairfield, IL 62837 Phone: 618-842-5285 Fax: 618-842-4576 |
Horizon Healthcare Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 213 Nw 10th St, Suite A, Fairfield, IL 62837 Phone: 618-842-4617 Fax: 618-842-4743 |
Horizon Healthcare Family Medicine Medicare: Medicare Enrolled Practice Location: 303 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-2611 |
Southern Illinois Primary Care Associates, P.c. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 209 Nw 11th St, Fairfield, IL 62837 Phone: 618-842-4470 Fax: 618-842-3437 |
News Archive
Microsoft, Visionshare partner to enhance health information transaction between physicians, patients
VisionShare, the nation's largest and most trusted healthcare information network, announced today that it is working with Microsoft Corp. to enhance the transaction of health information from physicians to their patients based on security protocols endorsed by the Office of the National Coordinator's Direct Project.
Micromet announces presentation of updated results from MT103 Phase 2 trial in MRD positive ALL patients
Micromet, Inc. today announced the presentation of updated results from a Phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with minimal residual disease (MRD) positive acute lymphoblastic leukemia (ALL). An analysis of long-term efficacy data demonstrated that blinatumomab produced prolonged remissions in patients with ALL. As of November 2010, the hematologic disease free survival (DFS) was 60%, with a follow-up of up to 27.5 months.
Catylix, Aspira Scientific partner to develop and commercialize new fluorination products
Catylix, Inc. (Burbank, California) and Aspira Scientific (Milpitas, California) announced today the formation of a joint venture to develop and commercialize new fluorination products and related chemistry.
RA synthetic derivative 4-HPR's ability to induce tumour cell death
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.
Genmab's HuMax-CD4 receives U.S. orphan drug designation
Genmab has announced that HuMax-CD4 for the treatment of Mycosis Fungoides (MF), which constitutes 75% of all Cutaneous T-cell Lymphomas (CTCL), has been designated an orphan drug by the US Food and Drug Administration (FDA). The US prevalence of MF is estimated at 16,000 to 20,000.
› Verified 9 days ago